## RUN: Sunrun Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -6.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($14.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. 3 Reasons RUN is Risky and 1 Stock to Buy Instead**
- Source: Finviz | 20251205T102400 | Neutral | Relevance: 97%
-  This article outlines three reasons why Sunrun (RUN) is considered a risky investment despite a recent surge in its stock price. These reasons include flatlining revenue growth, a significant cash burn rate, and a short cash runway coupled with high debt that could lead to dilution for shareholders. The author suggests looking for alternative investments due to Sunrun's foundational issues and advises caution until the company demonstrates consistent free cash flow.

**2. Why Sunrun (RUN) Shares Are Sliding Today**
- Source: Finviz | 20251203T114700 | Neutral | Relevance: 96%
-  Sunrun (NASDAQ:RUN) shares fell 2.5% after a director sold a significant number of shares, raising investor concerns about the company's near-term outlook. Broad industry concerns about rising prices for essential solar module components also contributed to the negative sentiment, potentially squeezing profit margins for solar companies. Despite a strong performance earlier in the year, these factors led to a decline in stock value.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $21 | $20 | +5% |
| 2025-11-11 | Wells Fargo | $21 | $14 | +50% |
| 2025-11-10 | Guggenheim | $27 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-11 | Wells Fargo | main | Overweight |
| 2025-11-10 | Guggenheim | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 15 ($4.47M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 16.1% (+0.2%)
- Vanguard Group Inc: 10.4% (+1.2%)
- Greenvale Capital, L: 5.8% (-2.1%)
- Shaw D.E. & Co., Inc: 4.1% (+533.8%)
- State Street Corpora: 4.0% (-0.9%)

### Key Risks

1. High beta (2.35) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-3.3% 5d) with bearish MACD, trend may be turning.
3. Insider selling cluster: $4.5M in recent transactions.
4. High short interest (28.7%, 6.3 days to cover): squeeze risk or crowded bearish bet.
5. Near-term weakness: 8.7% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.45 indicates undervaluation relative to growth. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($4.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.1B |
| Beta | 2.35 |
| 52W Range | $5.38 - $22.44 |
| Short Interest | 28.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.45 |
| Forward P/E | 22.9 |
| Current P/E | 12.9 |
| YoY Growth | -43.6% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -3.0% to -6.3% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.3pp (needs >3.0% for momentum thesis). Underperforming sector by 6.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.44x) but short-term weakness (below SMA20). RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -6.35% (CS: 3) | Weak |
| RSI_14 | 43.6 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 0.947x | Below |
| vs SMA50 | 0.913x | Below |
| vs SMA200 | 1.440x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $17.58
- **Stop Loss:** $14.80 (15.8% risk)
- **Target:** $20.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 359
- **Position Value:** $6,311.22
- **Portfolio %:** 6.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stabilizing volatility and moderate risk appetite. Fed in data-dependent mode with 7 days to FOMC—soft economic data (retail -4.67% MoM, CPI 2.89% rising) offsetting labor resilience. AI infrastructure demand and capital reallocation themes dominating corporate narratives, signaling selective risk-on in growth/tech segments. Narrow breadth (52% above 50MA) and neutral put/call suggest complacency but not excess—standard late-cycle positioning amid policy uncertainty.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.06 | -48.7% |
| 2025Q2 | $-0.12 | $1.07 | +1030.4% |
| 2025Q1 | $-0.27 | $0.20 | +173.5% |
| 2024Q4 | $-0.19 | $1.41 | +837.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*